BIOMAT Database Logo BIOMAT Database Logo

[Prothrombinemia in tuberculous persons of various ages during treatment with paraaminosalicylic acid]. 1950

E SORAGNI, and E REZZA, and A GHERARDINI

UI MeSH Term Description Entries
D010131 Aminosalicylic Acid An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid. 4-Aminosalicylic Acid,p-Aminosalicylic Acid,para-Aminosalicylic Acid,Alumino-4-Aminosalicylic Acid,Pamisyl,Rezipas,p-Aminosalicylic Acid Monolithium Salt,p-Aminosalicylic Acid Monopotassium Salt,p-Aminosalicylic Acid Monosodium Salt,p-Aminosalicylic Acid, Aluminum (2:1) Salt,p-Aminosalicylic Acid, Calcium (2:1) Salt,p-Aminosalicylic Acid, Monosodium Salt, Dihydrate,4 Aminosalicylic Acid,Acid, Aminosalicylic,Alumino 4 Aminosalicylic Acid,p Aminosalicylic Acid,p Aminosalicylic Acid Monolithium Salt,p Aminosalicylic Acid Monopotassium Salt,p Aminosalicylic Acid Monosodium Salt,para Aminosalicylic Acid
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D017127 Glycation End Products, Advanced A heterogeneous group of compounds derived from rearrangements, oxidation, and cross-linking reactions that follow from non-enzymatic glycation of amino groups in PROTEINS; LIPIDS; or NUCLEIC ACIDS. Their accumulation in vivo accelerates under hyperglycemic, oxidative, or inflammatory conditions. Heat also accelerates the formation of advanced glycation end products (AGEs) such seen with the browning of food during cooking. Advanced Glycation End Product,Advanced Glycation Endproduct,Advanced Maillard Reaction End Product,Glycated Lipids,Glycotoxins,Maillard Product,Maillard Reaction End Product,Maillard Reaction Product,Advanced Glycation End Products,Advanced Glycation Endproducts,Advanced Maillard Reaction End Products,Glycation Endproducts, Advanced,Maillard Products,Maillard Reaction End Products,Maillard Reaction Products,Glycation Endproduct, Advanced,Lipids, Glycated,Product, Maillard Reaction,Products, Maillard,Products, Maillard Reaction,Reaction Products, Maillard
D020156 Salicylic Acid A compound obtained from the bark of the white willow and wintergreen leaves. It has bacteriostatic, fungicidal, and keratolytic actions. 2-Hydroxybenzoic Acid,o-Hydroxybenzoic Acid,ortho-Hydroxybenzoic Acid,2 Hydroxybenzoic Acid,Acid, 2-Hydroxybenzoic,Acid, Salicylic,Acid, o-Hydroxybenzoic,Acid, ortho-Hydroxybenzoic,o Hydroxybenzoic Acid,ortho Hydroxybenzoic Acid

Related Publications

E SORAGNI, and E REZZA, and A GHERARDINI
[Local treatment of tuberculous empyema with paraaminosalicylic acid].
May 1951, Tuberkuloza,
E SORAGNI, and E REZZA, and A GHERARDINI
[Tuberculous pleural empyema; its treatment with paraaminosalicylic acid].
January 1950, Revista de la Asociacion Medica Argentina,
E SORAGNI, and E REZZA, and A GHERARDINI
[Treatment of primary tuberculous infection and paraaminosalicylic acid].
February 1952, Acta tuberculosea Belgica,
E SORAGNI, and E REZZA, and A GHERARDINI
[Concentration of paraaminosalicylic acid in tuberculous patients].
July 1952, Deutsches medizinisches Journal,
E SORAGNI, and E REZZA, and A GHERARDINI
Tuberculous pericarditis-Treatment with paraaminosalicylic acid and intermittent streptomycin. Report of a case.
December 1950, California medicine,
E SORAGNI, and E REZZA, and A GHERARDINI
[Tuberculous meningitis at various ages].
October 1953, Archivio di tisiologia e delle malattie dell'apparato respiratorio,
E SORAGNI, and E REZZA, and A GHERARDINI
[Treatment of tuberculosis with paraaminosalicylic acid].
April 1950, Schweizerische medizinische Wochenschrift,
E SORAGNI, and E REZZA, and A GHERARDINI
[Correlation rhythmography during functional loading in persons of various ages].
January 1986, Fiziologicheskii zhurnal,
E SORAGNI, and E REZZA, and A GHERARDINI
[Chaulmoogra oil, paraaminosalicylic acid, and thiosemicarbazones in tuberculous meningitis].
January 1954, Acta pediatrica espanola,
E SORAGNI, and E REZZA, and A GHERARDINI
[Treatment of tuberculosis with paraaminosalicylic acid; effect of vitamin C on paraaminosalicylic acid metabolism].
January 1951, Bratislavske lekarske listy,
Copied contents to your clipboard!